Haematological cancer: Lenalidomide maintenance--perils of a premature denouement.
S Vincent
SV
Rajkumar
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019468:Disease Management; D006402:Hematologic Diseases / Q000188:drug therapy*; D006801:Humans; D000077269:Lenalidomide; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide